NewsHealum care plans linked to a 7.4% average HbA1c reduction in an NHS primary care RCTRead the evidence
A man checks his blood sugar with a finger-prick test at home

For life sciences

Support patients beyond the prescription

Companion apps, remote monitoring and decentralised trials that help patients stay on treatment, let clinicians act sooner and gather real-world evidence, on a platform NHS teams already use.

Book a demo See what it helps you do
Clinical trialsDrug companions
On treatment

Staying on treatment

A companion app made with Healum helps Marcus through twelve weeks on a weekly injection. His nurse sees every dose, one message reaches everyone who hasn’t logged this week’s, and the maker gets weekly totals, never names. The brand and medicine here are made up.

Every MondayEach dose on his record. One not logged is flagged.

Everyone on the appDoses on time and who stays on treatment, week by week.

His plan, from his nurseTwelve weeks of support, shared from his record.

A missed doseOne message to the 41 who haven’t logged this week.

Evidence, not promises

Support people keep using

People stay with Healum long after they start, and its results in NHS care are published.

Read the evidence

95%

user retention across our GLP-1 programme settings.

Healum GLP-1 programmes

72.4%

of patients with a Healum care plan reduced their HbA1c, against 41.5% without.

NHS primary care RCT, Diabetes Therapy 2023

+8.2%

in self-rated health (EQ VAS) with Healum, against −2.8% without.

NHS primary care RCT, Diabetes Therapy 2023

What it helps you do

From the first dose to the evidence

One platform for patients, their clinicians and your teams, from finding the right patients to measuring what changed.

Better adherence

Reminders, plans and check-ins that help people take their medicine as prescribed, and stay on it.

Fair access to treatment

Care pathways that prompt clinicians to offer treatment where it fits, for every eligible patient.

Quality of life, measured

Patient-reported outcome and quality-of-life questionnaires, completed in the app between visits.

Insight into behaviour

How people use their medicine, their plan and the app, anonymised and in aggregate.

Find the right patients

Identify people who meet the criteria for treatment and haven’t been offered it yet.

Regulation, safety and compliance

UK-hosted, NHS DSPT and clinically safe by design. See the standards we meet.

Decentralised clinical trials

Run trials closer to home

Recruit participants from across the UK and let them take part from home, with digital engagement, study visits at home and remote data collection.

What's included

Precision recruitment, with equitable access across the UK
Study visits and care at home, or remotely
Remote data collection and digital endpoints from our tracker library
Side effect and adverse event monitoring
Continuous data and near real-time reporting
Real-world evidence for R&D and commercial decisions
Bigger, broader trialsWiden the size and scope of a trial, ease recruitment and reduce its cost.
Participants who stayLess travel and digital support ease the burden of taking part, with patient-reported outcomes and experience built in.
Book a demo
A nurse checks a woman’s blood pressure at home

Digital drug companions

Companions that keep treatment on track

A companion app in your brand, connected to each patient’s clinical team: support every day for patients, and an earlier view of who needs help for clinicians.

What's included

Engagement programmes that support adherence
Remote monitoring that shows who is out of range, with less admin
One view of each patient, to spot those at risk sooner
Side effect and adverse event reporting, to act before a hospital stay
Better-informed decisions and earlier intervention
Adherence and outcomesSupport between appointments helps people stay on treatment and get the most from it.
Real-world evidence at scaleAnonymised totals from everyone on the app, under your data agreement.
Book a demo
A smiling woman checks her blood sugar at home

Why Healum

Proven, connected and quick to launch

Healum already runs in live NHS and private settings, and connects to the clinical systems patients’ care teams use.

EMIS WebSystmOne

Evidence and assurance

Published RCT evidence in type 2 diabetes (Diabetes Therapy, 2023)

Eli Lilly-funded obesity pathway at University Hospitals Birmingham

Clinical safety: DCB0129 compliant

Live in as little as 13 weeks

Talk to us about your medicine or trial

We’ll show you the companion app, the clinician’s view and the evidence it gathers, in your brand.

Book a demo Contact us